RecruitingPhase 2NCT05288790

Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT

Studying Microtia

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Vanderbilt University Medical Center
Intervention: Probiotic(dietary_supplement)
Enrollment: 250 target
Eligibility: 18-89 years · All sexes
Timeline: 2023 – 2027

Study locations (1)

Vanderbilt University Medical Center, Nashville, Tennessee, United States

Collaborators

University of Louisville · Boston University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05288790 on ClinicalTrials.gov

Other trials for Microtia

Additional recruiting or active studies for the same condition.

RECRUITINGPHASE2NCT06087874
Preventive Effect of Perinatal Oral Probiotic Supplementation (POPS) on Neonatal Jaundice
Chinese University of Hong Kong
ACTIVE NOT RECRUITINGNCT06289283
Microbiota in Urine and Urothelium Can be a Factor for Induction of Urinary Bladder Cancer. The Study Will Examine Urine and Bladder Cancer Tissues From Male Patients and Urine of Controls Using Whole Genomic Sequencing Techniques and 16S rRNA. The Aim is to Elucidate Role of Microbiota in Bladder
Theodor Bilharz Research Institute

See all trials for Microtia →

← Back to all trials